SeaSpine Attracting New Surgeons and Distributors in 2022

SeaSpine reported 1Q22 orthopedic sales of $50.7 million, +20.8% compared to 1Q21.

The company said that COVID-related headwinds had a significant impact in January, but quickly recovered in February. SeaSpine believes most of its surgeons are back to "typical" waitlist periods of two to three months.

To date, SeaSpine has closed four...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us